Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Deloitte
McKinsey
UBS
Johnson and Johnson
Medtronic

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 10,064,921

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 10,064,921
Title:Botulinum toxin treatments of neurological and neuropsychiatric disorders
Abstract: Methods for preventing or treating neuropsychiatric disorder and/or a neurological disorder including a neurological disorder mediated by the thalamus. Neuropsychiatric disorders and/or a neurological disorders, including a thalamically mediated disorder can be treated by peripheral administration of a botulinum toxin to or to the vicinity of a trigeminal sensory nerve, thereby preventing or treating a neurological disorder and/or a neuropsychiatric disorder.
Inventor(s): Blumenfeld; Andrew M. (Del Mar, CA)
Assignee: Allergan, Inc. (Irvine, CA)
Application Number:15/447,770
Patent Claims:see list of patent claims

Details for Patent 10,064,921

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Elan Pharm MYOBLOC botulinum toxin type b VIAL 103846 001 2000-12-08 ➤ Sign Up Allergan, Inc. (Irvine, CA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 10,064,921

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2005084705 Sep 15, 2005
World Intellectual Property Organization (WIPO) 2005120136 Dec 15, 2005
World Intellectual Property Organization (WIPO) 2005120136 Dec 28, 2006
United States of America 2005147626 Jul 07, 2005
United States of America 2005264179 Dec 01, 2005
United States of America 2011200639 Aug 18, 2011
United States of America 2013142776 Jun 06, 2013
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Julphar
Chubb
Merck
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.